English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

With the exploration of new horizons in the frontiers of genetic linkage with head and neck cancer by advanced molecular biological technique it may be possible to know the various steps involved in the cancer development and new prognostic markers for not only predicting prognosis but also progression and predisposition including routine diagnostic tests for mutantgenes for a better diagnosis and treatment of squamous cell cancers of head and neck. Various oncogens and their products so far identified are ras, myc, c-erb, Bl, PRAD-.l, int-2, hst-1 and p 53 etc with lirikage to head and neck malignancy. The HLA gene association is the most convincing evidence for the role of genetics in the aetiology of nasopharyngeal cancer. EGFR looks to be a promising prognostic indicator as its interaction with the polypeptide epidermal growth factor stimulates proliferation of target cells.

Oncogens in ENT and head and neck — a review